cg0070,pembrolizumab
merck,kissei,cg oncology
['cg0070', 'pembro', 'nmibc', 'mibc']
today at #asco22, shares initial data from core1: a phase 2, single arm study looking at cg0070 combined with pembrolizumab to treat bcg-unresponsive #nmibc. view abstract: 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.